瓦尔酸三十年:研究自闭症谱系障碍的现有模型
David Zarate-Lopez1,2, Ana Laura Torres-Chávez1,2, Alma Yadira Gálvez-Contreras3
1Laboratory of Neuroscience, School of Psychology, University of Colima, Colima 28040, México.
Current neuropharmacology
|October 24, 2023
概括
产前暴露于酸 (VPA) 在动物中的自闭症谱系障碍 (ASD) 模型. 本综述详细介绍了VPA模型,强调了与ASD病理生理学相关的神经生物学变化.
科学领域:
- 神经科学是一个神经科学.
- 发展生物学 发展生物学
- 遗传学 遗传学 是一个
背景情况:
- 自闭症谱系障碍 (ASD) 是一种复杂的神经发育状况,患病率正在上升.
- 它的确切原因尚不清楚,但涉及影响大脑发育的遗传和环境因素.
- 在子宫内接触抗药物酸 (VPA) 与ASD风险增加有关.
结论:
- VPA动物模型是研究ASD病因和机制的宝贵工具.
- 它提供了关于VPA暴露等环境因素如何影响大脑发育和行为的见解.
- 将VPA模型与其他ASD模型进行比较,为自闭症研究提供了更广泛的视角.
相关概念视频
01:26Modeling in Therapy
92
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
92
01:19Autism Spectrum Disorder
104
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
104
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
318
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
318
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
425
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
425